March 1, 2019

In Vivo

Paying for Pharmaceutical Value: The Problem of a One-Size-Fits-All Definition

By Roger Longman, Chairman, Real Endpoints

Combining a set of tailored, regularly updated value assessments with risk-sharing contracts allows us to deal with evidentiary uncertainty by paying for what works, thereby getting us closer to a health care system that provides the choice Americans demand aligned to the value the choices provide.

read full insight article >